Published July 20, 2012 | Version v1
Journal article

Fabrication of electrolytic cell for online post-column electrochemical derivatization in ion chromatography

  • 1. Department of Chemistry, Xixi Campus, Zhejiang University, Hangzhou 310028, Zhejiang (China)
  • 2. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310028, Zhejiang (China)
  • 3. School of Pharmacy, East China University of Science and Technology, Shanghai 200237 (China)
  • 4. Thermofisher scientific (China), Shanghai 201203 (China)
  • 5. College of Biology and Environmental Engineering, Zhejiang Shuren University, Hangzhou 310015 (China)

Description

Highlight: ► An electrolytic cell including ruthenium modified titanium electrode was fabricated. ► Ion chromatography/electrochemical derivatization/fluorescence detection was developed. ► Strong oxidation capacity of this EC was obtained by using the Ru/Ti electrode with large surface area. - Abstract: An electrolytic cell (EC), composed of two ruthenium-plated titanium electrodes separated by cation-exchange membranes, was fabricated and evaluated for online postcolumn derivatization in ion chromatography (IC). Folic acid (FA) and methotrexate (MTX) were preliminarily used as prototype analytes to test the performance of EC. After separation by an anion exchange column, FA and MTX, which emit very weak fluorescence when excited, were electrochemically oxidized online in the anode chamber of the EC. The compounds with strong fluorescence, which are oxidation products, were detected by the fluorescence detector. The phosphate buffer solution (100 mM KH2PO4) served as an optimal eluent for anion exchange chromatographic separation and a suitable supporting electrolyte for electro-oxidation, leading to ideal compatibility between IC separation and the postcolumn electrochemical derivatization. For the presently proposed method, the linear ranges were from 0.01 mg L−1 to 5 mg L−1 for both FA and MTX. The detection limits of FA and MTX were 1.8 and 2.1 μg L−1, and the relative standard deviations (RSD, n = 7) were 2.9% and 3.6%, respectively. The method was applied for the simultaneous determination of FA and MTX in the plasma of patients being treated for rheumatoid arthritis. The determination of MTX in the urine of the patients of diffuse large B cell lymphoma was also demonstrated.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.aca.2012.05.014

Additional details

Identifiers

DOI
10.1016/j.aca.2012.05.014;
PII
S0003-2670(12)00725-8;

Publishing Information

Journal Title
Analytica Chimica Acta
Journal Volume
735
Journal Page Range
p. 62-68
ISSN
0003-2670
CODEN
ACACAM

Optional Information

Copyright
Copyright (c) 2012 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.